Menu

NYU Medical School Is Now Free, Almost

All students’ tuition will be funded through its endowment.

Aug 17, 2018
Shawna Williams

ABOVE: WIKIMEDIA, KENNETH WILSEY

In a surprise announcement made at the end of the school’s annual white coat ceremony for new medical students on Thursday (August 16), the chair of the board of trustees for New York University School of Medicine declared that all students will now attend tuition-free. The change will save current and future students approximately $55,000 per year.

“It makes an enormous difference in our students[’] lives,” Robert Grossman, a dean at the school and CEO of NYU Langone Health, tell STAT News. “We think it will, at some level, relieve one source of stress in medical training.”

Tuition will be paid through an endowment that now sits at $450 million, STAT reports; the school is continuing to fundraise with hopes of bringing it to $600 million. Students will still be on the hook for about $27,000 per year in room, board, and fees, The New York Times notes.

NYU is the first top-10 ranked medical school in the US to offer free tuition, according to the school’s announcement. The Association of American Medical Colleges has found that 75 percent of medical students graduate with education debt—an average of more than $190,000 each.

“[O]ur hope—and expectation—is that by making medical school accessible to a broader range of applicants, we will be a catalyst for transforming medical education nationwide,” says Kenneth Langone, chair of the Board of Trustees of NYU Langone Health, in the school’s statement.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.